Breakthrough AI tools now detect Alzheimer’s years before symptoms through speech patterns and retinal scans, creating new digital biomarkers that could transform treatment paradigms. Advanced A...
New research shows combining Mediterranean polyphenols with ketogenic fats improves mitochondrial function in HD models, while time-restricted eating enhances therapeutic ketosis and autophagy. Phase ...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and cognitive performance in early-stage Huntington’s disease. Groundbreaking researc...
A new clinical trial explores time-restricted eating for Huntington’s disease, building on recent research showing benefits for mitochondrial function and autophagy. A groundbreaking clinical trial ...
A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
Johns Hopkins Hospital’s pilot study reveals ADAM sensors with AI biofeedback improve swallow frequency by 45%, reducing aspiration pneumonia risk by 32%, now under FDA fast-track review. Breakt...
A 12-week clinical trial explores time-restricted eating’s effects on cognitive function and mitochondrial health in Huntington’s disease patients. New research investigates whether time-restr...
New clinical trial explores time-restricted eating’s potential benefits for Huntington’s disease patients, focusing on metabolic health and symptom management. A groundbreaking clinical tr...
A recent PLoS One study reveals that a 12-week time-restricted eating protocol improves mitochondrial function and reduces polyQ aggregation in Huntington’s disease patients. Groundbreaking rese...
